Staar Surgical (STAA) Stock Forecast & Price Target

Q: What is STAA’s average 12-month price target, according to analysts?

Based on analyst ratings, Staar Surgical Company’s 12-month average price target is 30.75.

Q: What is STAA’s upside potential, based on the analysts’ average price target?

Staar Surgical Company has 21.78% upside potential, based on the analysts’ average price target.

Q: Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

Q: How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Q: Is STAA a Buy, Sell or Hold?

Staar Surgical Company has a consensus rating of Hold which is based on 0 buy ratings, 3 hold ratings and 0 sell ratings.

Q: What is Staar Surgical Company’s price target?

The average price target for Staar Surgical Company is 30.75. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $30.75 ,the lowest forecast is $30.75. The average price target represents 21.78% Increase from the current price of $25.25.

Q: What do analysts say about Staar Surgical Company?

Staar Surgical Company’s analyst rating consensus is a Hold. This is based on the ratings of 3 Wall Streets Analysts.

Q: How can I buy shares of STAA?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Compare

559 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

STAA Analyst Ratings

Hold

0 Buy

3 Hold

0 Sell

Based on 3 analysts giving stock ratings to

Staar

Surgical

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

STAA Stock 12 Month Forecast

Average Price Target

$30.75

▲(21.78% Upside)

Based on 3 Wall Street analysts offering 12 month price targets for Staar Surgical in the last 3 months. The average price target is $30.75 with a high forecast of $30.75 and a low forecast of $30.75. The average price target represents a 21.78% change from the last price of $25.25.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"15":"$15","19":"$19","23":"$23","27":"$27","31":"$31"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":30.75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$30.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":30.75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$30.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":30.75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$30.75</span>\n  </div></div>","useHTML":true}}],"tickPositions":[15,19,23,27,31],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Feb<br/>2025","6":"May<br/>2025","9":"Aug<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,25.91,26.282307692307693,26.654615384615386,27.026923076923076,27.39923076923077,27.771538461538462,28.143846153846155,28.516153846153845,28.888461538461538,29.26076923076923,29.633076923076924,30.005384615384614,30.377692307692307,{"y":30.75,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,25.91,26.282307692307693,26.654615384615386,27.026923076923076,27.39923076923077,27.771538461538462,28.143846153846155,28.516153846153845,28.888461538461538,29.26076923076923,29.633076923076924,30.005384615384614,30.377692307692307,{"y":30.75,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,25.91,26.282307692307693,26.654615384615386,27.026923076923076,27.39923076923077,27.771538461538462,28.143846153846155,28.516153846153845,28.888461538461538,29.26076923076923,29.633076923076924,30.005384615384614,30.377692307692307,{"y":30.75,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":28.56,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.72,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.29,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.19,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.5,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.6,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.34,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.69,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.02,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.76,"date":1754006400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":27.18,"date":1759276800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":25.87,"date":1761955200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":25.91,"date":1764547200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$30.75

Average Price Target$30.75

Lowest Price Target$30.75

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

John Young CFA

Canaccord Genuity

$28→$30.75

Hold

21.78%

Upside

Reiterated

12/10/25

Hold Rating Maintained Amidst Alcon-Staar Merger Developments and Valuation Considerations

David Saxon

Needham

―

Hold

―

Reiterated

12/09/25

Analysts Offer Insights on Healthcare Companies: Staar Surgical (NASDAQ: STAA) and Diamedica Therapeutics (NASDAQ: DMAC)We reiterate our Hold rating on STAA

Ryan Zimmerman

BTIG

―

Hold

―

Reiterated

11/11/25

BTIG Remains a Hold on Staar Surgical (STAA)

Simran Kaur

Wells Fargo

Not Ranked

Wells Fargo

$28

Hold

10.89%

Upside

Reiterated

08/18/25

Analysts' Opinions Are Mixed on These Healthcare Stocks: Alkermes (NASDAQ: ALKS), Staar Surgical (NASDAQ: STAA) and Arvinas Holding Company (NASDAQ: ARVN)

Thomas Stephan

Stifel Nicolaus

$28

Hold

10.89%

Upside

Downgraded

08/07/25

Staar Surgical downgraded to Hold from Buy at StifelStaar Surgical downgraded to Hold from Buy at Stifel

Simran Kaur

Wells Fargo

Not Ranked

Wells Fargo

$17→$28

Hold

10.89%

Upside

Reiterated

08/06/25

Wells Fargo Sticks to Their Hold Rating for Staar Surgical (STAA)

Raj Denhoy

Jefferies

$21→$28

Hold

10.89%

Upside

Reiterated

08/06/25

Jefferies Remains a Hold on Staar Surgical (STAA)

James Sidoti

Sidoti

$27→$28

Hold

10.89%

Upside

Downgraded

08/05/25

Staar Surgical downgraded to Neutral from Buy at SidotiStaar Surgical downgraded to Neutral from Buy at Sidoti

Anthony Petrone

Mizuho Securities

$17→$18

Hold

-28.71%

Downside

Reiterated

07/16/25

Mizuho Securities Sticks to Its Hold Rating for Staar Surgical (STAA)

Adam Maeder

Piper Sandler

$16

Hold

-36.63%

Downside

Reiterated

06/18/25

Piper Sandler Remains a Hold on Staar Surgical (STAA)

Patrick Wood

Morgan Stanley

$13

Sell

-48.51%

Downside

Reiterated

05/08/25

Cautious Outlook on Staar Surgical Amid Market Challenges and Guidance Withdrawal

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

John Young CFA

Canaccord Genuity

$28→$30.75

Hold

21.78%

Upside

Reiterated

12/10/25

Hold Rating Maintained Amidst Alcon-Staar Merger Developments and Valuation Considerations

David Saxon

Needham

―

Hold

―

Reiterated

12/09/25

Analysts Offer Insights on Healthcare Companies: Staar Surgical (NASDAQ: STAA) and Diamedica Therapeutics (NASDAQ: DMAC)We reiterate our Hold rating on STAA

Ryan Zimmerman

BTIG

―

Hold

―

Reiterated

11/11/25

BTIG Remains a Hold on Staar Surgical (STAA)

Simran Kaur

Wells Fargo

Not Ranked

Wells Fargo

$28

Hold

10.89%

Upside

Reiterated

08/18/25

Analysts' Opinions Are Mixed on These Healthcare Stocks: Alkermes (NASDAQ: ALKS), Staar Surgical (NASDAQ: STAA) and Arvinas Holding Company (NASDAQ: ARVN)

Thomas Stephan

Stifel Nicolaus

$28

Hold

10.89%

Upside

Downgraded

08/07/25

Staar Surgical downgraded to Hold from Buy at StifelStaar Surgical downgraded to Hold from Buy at Stifel

Simran Kaur

Wells Fargo

Not Ranked

Wells Fargo

$17→$28

Hold

10.89%

Upside

Reiterated

08/06/25

Wells Fargo Sticks to Their Hold Rating for Staar Surgical (STAA)

Raj Denhoy

Jefferies

$21→$28

Hold

10.89%

Upside

Reiterated

08/06/25

Jefferies Remains a Hold on Staar Surgical (STAA)

James Sidoti

Sidoti

$27→$28

Hold

10.89%

Upside

Downgraded

08/05/25

Staar Surgical downgraded to Neutral from Buy at SidotiStaar Surgical downgraded to Neutral from Buy at Sidoti

Anthony Petrone

Mizuho Securities

$17→$18

Hold

-28.71%

Downside

Reiterated

07/16/25

Mizuho Securities Sticks to Its Hold Rating for Staar Surgical (STAA)

Adam Maeder

Piper Sandler

$16

Hold

-36.63%

Downside

Reiterated

06/18/25

Piper Sandler Remains a Hold on Staar Surgical (STAA)

Patrick Wood

Morgan Stanley

$13

Sell

-48.51%

Downside

Reiterated

05/08/25

Cautious Outlook on Staar Surgical Amid Market Challenges and Guidance Withdrawal

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Staar Surgical

1 Month

xxx

Success Rate

4/6 ratings generated profit

Average Return

+6.08%

reiterated a xxx

rating 7 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +6.08% per trade.

3 Months

xxx

Success Rate

4/6 ratings generated profit

Average Return

+6.85%

reiterated a xxx

rating 7 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +6.85% per trade.

1 Year

Patrick WoodMorgan Stanley

Success Rate

4/6 ratings generated profit

Average Return

+3.12%

reiterated a sell rating 7 months ago

Copying Patrick Wood's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +3.12% per trade.

2 Years

xxx

Success Rate

4/6 ratings generated profit

Average Return

+3.80%

reiterated a xxx

rating 7 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +3.80% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

STAA Analyst Recommendation Trends

Rating

Jul 25

Aug 25

Oct 25

Nov 25

Dec 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, STAA has received 0 Buy Ratings, 14 Hold Ratings, and 0 Sell Ratings. STAA average Analyst price target in the past 3 months is 30.75.

Each month's total comprises the sum of three months' worth of ratings.

STAA Financial Forecast

STAA Earnings Forecast

Next quarter’s earnings estimate for STAA is $0.10 with a range of <$0.01 to $0.28. The previous quarter’s EPS was $0.34. STAA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year STAA has Performed in-line its overall industry.

STAA Sales Forecast

Next quarter’s sales forecast for STAA is $75.38M with a range of $72.30M to $78.30M. The previous quarter’s sales results were $94.73M. STAA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year STAA has Performed in-line its overall industry.

STAA Stock Forecast FAQ

What is STAA’s average 12-month price target, according to analysts?

Based on analyst ratings, Staar Surgical Company’s 12-month average price target is 30.75.

What is STAA’s upside potential, based on the analysts’ average price target?

Staar Surgical Company has 21.78% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is STAA a Buy, Sell or Hold?

Staar Surgical Company has a consensus rating of Hold which is based on 0 buy ratings, 3 hold ratings and 0 sell ratings.

What is Staar Surgical Company’s price target?

The average price target for Staar Surgical Company is 30.75. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $30.75 ,the lowest forecast is $30.75. The average price target represents 21.78% Increase from the current price of $25.25.

What do analysts say about Staar Surgical Company?

Staar Surgical Company’s analyst rating consensus is a Hold. This is based on the ratings of 3 Wall Streets Analysts.

How can I buy shares of STAA?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Staar Surgical (STAA) Stock Forecast & Price Target

STAA Analyst Ratings

STAA Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Staar Surgical

STAA Analyst Recommendation Trends

STAA Financial Forecast

STAA Earnings Forecast

STAA Sales Forecast

STAA Stock Forecast FAQ

Detailed List of Analyst Forecasts